CD3 Leuven Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 1

Professionals

  • Investments
  • 6

  • Portfolio
  • 4

  • Exits
  • 1

Exits

CD3 Leuven General Information

Company Description

Founded in 2006, CD3 Leuven is a venture capital firm based in Leuven, Belgium. The firm prefers to invest in the biotechnology and pharma sectors.

Business Details

Website
www.cd3.be
Year Founded
2006
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • Bio-incubator 2
  • Gaston Geenslaan 2
  • 3001 Leuven
  • Belgium
+32 016

CD3 Leuven Investments (6)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Enedra Therapeutics 08-May-2025 Early Stage VC Drug Discovery Clinical Trials - General
Rewind Therapeutics 25-Jan-2023 Drug Discovery Generating Revenue
Endlyz Therapeutics 29-Jul-2021 Drug Discovery Startup
Cytura Therapeutics 23-Apr-2019 Drug Discovery Generating Revenue
Rewind Therapeutics 04-Jan-2018 Early Stage VC Drug Discovery Generating Revenue
Arcarios 25-Aug-2010 Seed Round Drug Discovery Out of Business
To view CD3 Leuven’s complete investments history, request access »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CD3 Leuven Exits (1)

Company Name Exit Date Exit Type Exit Size
Arcarios 01-Nov-2016
To view CD3 Leuven’s complete exits history, request access »

CD3 Leuven Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

CD3 Leuven Co-Investors (8)

Name With Exits Lead Partner Series Industry
AXA Investment Managers 1 Series chart Industry bar
Cancer Research Technology Series chart Industry bar
M Ventures Series chart Industry bar
PMV (Belgium) Series chart Industry bar
Sunstone Life Science Ventures Series chart Industry bar
You’re viewing 5 of 8 co-investors. Get the full list »

CD3 Leuven FAQs

  • What is CD3 Leuven?

    Founded in 2006, CD3 Leuven is a venture capital firm based in Leuven, Belgium.

  • When was CD3 Leuven founded?

    CD3 Leuven was founded in 2006.

  • Where is CD3 Leuven headquartered?

    CD3 Leuven is headquartered in Leuven, Belgium.

  • What is CD3 Leuven's total asset value?

    CD3 Leuven has around in total assets under management.

  • How many investments has CD3 Leuven made?

    CD3 Leuven has made 6 investments.

  • What has CD3 Leuven invested in?

    CD3 Leuven has made numerous investments in companies like Enedra Therapeutics, Rewind Therapeutics, and Endlyz Therapeutics within the Drug Discovery industry.

  • What has CD3 Leuven invested in recently?

    CD3 Leuven's latest investment was on 08-May-2025 in Enedra Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process